Wound7 EB Guide for Wound
EN|็น|็ฎ€
Home / Treatment Principles

Treatment & Alerts

Core clinical logic: confirm perfusion and etiology first, then decide on debridement, compression, offloading/pressure redistribution, anti-infective, or immunomodulatory therapy; advanced dressings are adjuncts and cannot replace etiology-directed treatment.

Part 1: Six Etiology-Based Treatment Pathways

General rule: etiology first, dressing second. The "core interventions" in each pathway are non-negotiable steps.

Pathway 1: Diabetic Foot Ulcer (DFU)

  1. Assessment: neuropathy (monofilament) + vascular status (ABI / WIfI when indicated) + infection grading + suspicion of osteomyelitis
  2. Offloading: total contact cast / non-removable walker boot is first-line โ€” dressings cannot replace offloading
  3. Debridement: regular removal of callus and necrotic tissue (when perfusion is adequate)
  4. Infection: no antibiotics for uninfected ulcers; treat infection by mild/moderate/severe grade; if osteomyelitis is suspected, pursue further imaging / bone sampling
  5. Dressings: choose basic dressings by exudate, comfort, and cost (see Dressings & Wet Gauze)
  6. Advanced therapies: NPWT / oxygen therapy / cellular and matrix products โ€” only after standard care has been optimized
  7. Recurrence prevention: therapeutic footwear, regular foot examinations, patient education
IWGDF 2023 (incl. offloading DOI:10.1002/dmrr.3647; interventions guideline); IWGDF/IDSA 2023; Lavery 2024 WHS DOI:10.1111/wrr.13133

Pathway 2: Pressure Injury

  1. Pressure redistribution: scheduled repositioning + appropriate support surface (high-specification foam / dynamic air mattress for high-risk patients)
  2. Nutrition: screen and correct calorie / protein / micronutrient deficits
  3. Debridement: remove necrotic tissue (stable dry heel eschar is the exception)
  4. Infection / osteomyelitis: evaluate and treat when clinically suspected
  5. Dressings: by stage and exudate (stage ร— dressing matrix)
  6. NPWT / reconstruction: consider for large Stage 3โ€“4 injuries once the wound bed is optimized
EPUAP/NPIAP/PPPIA 2019; Gould 2024 WHS DOI:10.1111/wrr.13130

Pathway 3: Arterial Ulcer

  1. Objective perfusion assessment (ABI, toe pressure, TcPOโ‚‚โ€ฆ) + WIfI staging
  2. Revascularization: prioritize when feasible (endovascular or bypass)
  3. Necrosis management: stable dry necrosis โ†’ protect and keep dry; no aggressive debridement before perfusion is restored
  4. Avoid inappropriate compression; control risk factors (smoking cessation, lipids, glycemia)
  5. Dressings: choose a moist or dry strategy based on "healability"
Federman 2024 WHS DOI:10.1111/wrr.13204; Conte 2019 GVG DOI:10.1016/j.jvs.2019.02.016

Pathway 4: Venous Ulcer

  1. Exclude arterial disease first (ABI; adjust compression strength in mixed disease)
  2. Compression therapy: multilayer bandaging / compression stockings โ€” the cornerstone of treatment
  3. Exudate management and periwound skin protection
  4. Venous intervention: correcting superficial venous reflux accelerates healing and reduces recurrence
  5. Recurrence prevention: long-term compression stockings, activity and leg-elevation education
Marston 2016 WHS DOI:10.1111/wrr.12394; Franks 2016 EWMA; Lurie 2020 CEAP

Pathway 5: Atypical / Malignant / Palliative Wounds

  1. Diagnose first: biopsy + etiologic workup (Pyoderma gangrenosum, vasculitis, calciphylaxis, malignancy)
  2. Disease-specific therapy: immunomodulation (Pyoderma gangrenosum/vasculitis), metabolic management (calciphylaxis), oncologic treatment
  3. Avoid aggressive debridement in active Pyoderma gangrenosum (pathergy)
  4. Symptom-directed dressings: exudate / odor / bleeding / pain / infection / periwound skin (palliative goals)
Isoherranen 2019 EWMA; EWMA Palliative 2025; Maverakis 2020; Nigwekar 2018

Pathway 6: Debridement Decision (Common to All Etiologies)

MethodIndicationsCautions
Sharp / surgicalExtensive necrosis, infection source control, bedside or operating roomRequires adequate perfusion, hemostasis conditions, and specialized training
Autolytic (hydrogel/hydrocolloid)Small amounts of slough, pain-sensitive patientsSlow; should not be used alone on infected wounds
Moist gauzeโ€“assisted autolysis (wet-to-moist gauze)Short-term softening of thin, soft, loose sloughWring until moist but not dripping, change before drying, pack cavities loosely; contraindicated on ischemic dry eschar; switch strategy if no progress within 1โ€“2 weeks (see dressing-change technique)
Mechanical (irrigation / monofilament fiber pads)Superficial sloughWet-to-dry (ripping off dried gauze) is not recommended for routine use โ€” non-selective, painful, damages granulation and new epithelium
Enzymatic / technologicalPatients unsuitable for surgeryDepends on product availability
Biological (maggot therapy)Selected necrotic woundsAcceptance and supply
Delay or avoid debridement: severe ischemia without revascularization, stable dry heel eschar, active Pyoderma gangrenosum, uncorrected coagulopathy, malignant wounds (symptomatic management only).
EWMA Wound Debridement Pathway 2025; WHS guideline series

Part 2: Three-Tier Acute Triage (Acute Wounds)

๐Ÿ”ด Tier 1: Immediate Emergency Department / Activate Trauma or Specialty Team (any single criterion triggers a red alert)

๐ŸŸ  Tier 2: Same-Day Specialist Evaluation or Referral

๐ŸŸข Tier 3: Routine Outpatient Management and Follow-up (ALL of the following conditions must be met simultaneously)

Part 3: Chronic Wound Alerts

๐Ÿšจ Any single criterion below warrants urgent / expedited referral

The most important logic on this clinical site: confirm perfusion and etiology first, then decide on debridement, compression, offloading/pressure redistribution, anti-infective, or immunomodulatory therapy; advanced dressings are adjuncts and cannot replace etiology-directed treatment.
Wet gauze dressing reminder: wet-to-moist gauze is appropriate only after perfusion has been confirmed, for "short-term" autolytic debridement assistance on thin, loose slough; never moisten ischemic dry eschar, do not pack cavities tightly, and soak adherent gauze before removal. Needing 3โ€“4 changes per day yet still drying out or leaking means it is time to switch to another dressing (full principles).

Part 4: Wound Infection โ€” Signs, Diagnosis, Treatment & Cautions

Core reminder: A positive wound culture does not equal wound infection. Most open wounds are colonised by bacteria; infection is diagnosed primarily by clinical signs, not by culture reports alone.

4.1 The infection continuum (IWII 2022)

StageMeaningGeneral management
ContaminationTransient microorganisms, not multiplyingRoutine cleansing, observation
ColonisationBacteria multiplying without tissue damage or clinical infectionNo antibiotics
Local infectionMicroorganisms begin causing local tissue damageLocal infection control, debridement; systemic antibiotics by severity
Spreading infectionInfection extends beyond the wound border into surrounding tissueSystemic antibiotics; assess drainage or surgery
Systemic infectionSepsis or distant organ involvementEmergency referral, IV antibiotics and source control

4.2 Signs of infection

Classic local signs: expanding periwound redness and swelling, increased local warmth, new or increasing pain/tenderness, induration, purulent/turbid/viscous discharge, sudden increase or change of exudate, new or marked malodour, wound dehiscence or sudden deterioration of a stable wound, periwound maceration or breakdown.

โš ๏ธ Interpretation caution: "yellow discharge" or "wound odour" alone does not prove infection โ€” necrotic tissue, overdue dressing changes and heavy exudate can also produce odour.

Subtle signs in chronic wounds (diabetes, ischemia, neuropathy, immunosuppression and older age may mask classic redness/heat/swelling/pain): stalled or suddenly slowed healing, increasing size or depth, edge breakdown / undermining / new sinus tracts, granulation turning dark, friable or easily bleeding, healthy granulation turning necrotic, increasing exudate/pain/odour, suddenly increased dressing-change frequency, unexplained or hard-to-control hyperglycemia, general fatigue, reduced appetite or sudden functional decline.

Signs of spread: redness extending beyond the border and enlarging, cellulitis, red streaks along lymphatics, marked induration/pain/edema of surrounding tissue, deep abscess or fluctuance, rapid enlargement or tissue necrosis, painful joint motion, exposed tendon or bone, crepitus / subcutaneous gas / bullae.

Systemic infection / sepsis warnings: fever or chills (severe cases may be hypothermic), tachycardia, tachypnea, hypotension, confusion or drowsiness, reduced urine output, marked weakness with cold clammy skin, sudden metabolic or glycemic deterioration.

High-risk groups: diabetes, peripheral arterial disease, renal failure and immunosuppression โ€” absence of fever does not exclude severe infection.

4.3 Diagnosis

Clinical diagnosis is the core: assess cause/duration/rate of change, location and dimensions with undermining and sinuses, necrosis/pus/exudate/odour/granulation, extent of redness, pain, warmth and induration, foreign bodies, implants, dead space or abscess, perfusion, sensation, edema and pressure sources, comorbidities and prior antibiotics. For lower-limb/foot wounds, infection assessment cannot replace vascular assessment โ€” infection plus ischemia markedly increases necrosis, amputation and treatment failure.

Microbiological cultureContent
IndicatedEstablished clinical infection; moderate/severe or rapidly progressing; no improvement on antibiotics; recurrent infection; suspected resistant/atypical/nosocomial organisms; deep abscess/osteomyelitis/implant infection; immunosuppressed patients
Correct samplingCleanse first and remove surface contamination, pus and loose necrotic tissue; prefer deep tissue, debrided tissue or pus; deep swab after cleansing only when tissue unavailable; bone specimens outperform surface cultures for suspected osteomyelitis; request anaerobes/fungi/mycobacteria for special exposures or chronic infection
Not recommendedRoutine culture without clinical signs; swabbing an uncleansed wound surface; starting antibiotics because of a positive culture alone; judging infection by bacterial counts alone

Blood tests (by severity): CBC with differential; CRP/ESR (procalcitonin if needed); glucose, renal/liver function, electrolytes; lactate when hypoperfusion or sepsis suspected; blood cultures for fever, chills, hypotension or suspected bacteremia. Normal WBC or CRP cannot fully exclude infection, especially in older, diabetic, ischemic or immunosuppressed patients.

Clinical concernConsider
Deep abscess, fluid collectionUltrasound or CT
Foreign body, bone destruction, soft-tissue gasPlain X-ray
Osteomyelitis, deep fascial or muscle infectionMRI
Impaired perfusionABI, TBI, Doppler, vascular imaging
Suspected osteomyelitis, MRI unsuitableNuclear medicine or other advanced imaging

Suspected diabetic foot osteomyelitis: combine probe-to-bone, X-ray and inflammatory markers first; MRI when still uncertain (IWGDF/IDSA 2023).

4.4 Treatment

Principle: never "antibiotics only" โ€” address the infection source, the wound environment and the underlying etiology together.

โ‘  Source control: drain abscesses and deep collections; remove devitalised necrotic tissue; manage hematoma, dead space, sinuses and fistulae; assess and remove infected foreign bodies or implants; necrotising soft-tissue infection needs emergency surgical exploration and wide debridement; assess revascularisation concurrently when infection coexists with ischemia. Antibiotics alone usually cannot cure an undrained abscess, infected necrotic tissue or a gross foreign-body infection.

โ‘ก Local wound management: cleanse with saline or an appropriate solution; choose surgical/sharp/mechanical/autolytic or other debridement by perfusion and etiology; control excess exudate to prevent maceration; use low-adherence dressings with adequate absorbency; antimicrobial dressings or wound antiseptics may be used short-term under professional assessment with a defined review date; do not rotate antimicrobial dressings indefinitely without improvement โ€” re-examine for ischemia, abscess, osteomyelitis, malignancy or misdiagnosis.

โš ๏ธ Avoid harm: do not repeatedly irrigate wounds with alcohol, hydrogen peroxide or concentrated, inadequately diluted antiseptics โ€” cytotoxicity delays healing.

โ‘ข Systemic antibiotics โ€” indicated for: redness spreading beyond the wound, cellulitis or lymphangitis, deep soft-tissue infection, abscess/osteomyelitis/implant infection, fever/chills/hypotension or other systemic response, clinically infected diabetic foot, established infection in the immunocompromised. Selection: severity and likely pathogens, wound type and special exposures, culture and antibiotic history, MRSA/resistance risk, allergies and renal/hepatic function and interactions, local resistance data, culture and susceptibility results. Start appropriate empiric therapy, then de-escalate once cultures return; oral for mild cases, admission and IV for severe infection, sepsis or unreliable oral absorption. Duration: about 1โ€“2 weeks for diabetic-foot soft-tissue infection (IWGDF/IDSA 2023); markedly longer for osteomyelitis, implant infection or inadequate source control โ€” no single duration fits all wounds.

โ‘ฃ Treat the underlying cause: diabetic foot = offloading + glycemic control + perfusion; venous ulcer = compression after infection control once arterial supply acceptable; arterial ulcer = prioritise ischemia and revascularisation; pressure injury = immediate pressure redistribution and repositioning; edema-related wounds = manage edema and skin barrier; surgical wounds = evaluate fascia, implants, dead space and deep organ infection; malignant wounds = distinguish colonisation, local infection and tumour necrosis โ€” goals often symptom-focused.

4.5 Follow-up (reassess at 48โ€“72 hours)

Assess: redness shrinking or spreading; pain, exudate, pus and odour decreasing; temperature, blood pressure, mental state and appetite improving; residual deep abscess or necrosis; culture results requiring antibiotic adjustment; need for surgical, vascular or infectious-disease consultation.

If not improving, reconsider: undrained or uncleared source, peripheral arterial ischemia, osteomyelitis, resistant or uncovered pathogens, foreign-body or implant infection, fungal/mycobacterial or other atypical infection, vasculitis, pyoderma gangrenosum or other inflammatory disease, malignant wound, contact dermatitis mistaken for infection.

4.6 Important cautions

Do NOT use antibiotics for: simple colonisation without clinical signs; a positive culture alone; "prophylaxis" or to promote chronic-wound healing; exudate, necrotic tissue or odour alone without other evidence of infection.

Antimicrobial stewardship: most leg ulcers are colonised but not necessarily infected; antibiotics are for wounds with clinical signs of infection (NICE NG152).

Do not self-manage: diabetic foot wounds; a cold, blackened foot, weak pulses or rest pain; deep wounds with visible tendon or bone; bites, puncture wounds or heavily contaminated wounds; dehisced surgical wounds or exposed implants; immunosuppression, chemotherapy, transplantation or long-term steroids; recurrent, refractory or unexplained infection; rapidly enlarging wounds or pain out of proportion to appearance.

4.7 Emergency red flags

Any one of the following warrants immediate ED referral or urgent surgical evaluation:

Core reminder: wound infection is diagnosed primarily by clinical signs, not by a positive culture alone; treatment must combine source control, perfusion improvement and management of the underlying etiology โ€” antibiotics cannot replace drainage, debridement, offloading or vascular therapy.
Sources: IWII Wound Infection in Clinical Practice 2022 (3rd international consensus); IWGDF/IDSA 2023 (DOI: 10.1002/dmrr.3687); NICE NG152; CDC SSI Basics โ€” full references in the Guidelines Library.

Part 5: Universal Safety Checklist for All Tiers

Tetanus management should determine vaccine and TIG needs based on wound type and vaccination history; antibiotics must not substitute for tetanus prophylaxis (CDC clinical guidance on tetanus in wound management). Overall trauma triage should follow systematic primary assessment and appropriate level-of-care transfer principles (ACS Field Triage Guidelines).

Last updated: 2026-08-31